CHIKAKO RIESTER: Open Payments
NPI 1386997542 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 109 payments from 14 companies in 2025. Trend: 2023 $1,519 · 2024 $1,844 · 2025 $2,253
Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $676 |
| Amgen Inc. | 22 | $372 |
| UCB, Inc. | 16 | $303 |
| Janssen Biotech, Inc. | 12 | $258 |
| Novartis Pharmaceuticals Corporation | 10 | $218 |
| AstraZeneca Pharmaceuticals LP | 6 | $115 |
| SOBI, INC | 3 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Sandoz Inc. | 3 | $50 |
| PFIZER INC. | 2 | $32 |
Products named: RINVOQ, Bimzelx, SKYRIZI, TREMFYA, COSENTYX, KRYSTEXXA, SAPHNELO, Kineret.
Industry payments across SC — which companies pay providers there.
